COMMUNIQUÉS West-GlobeNewswire
 
      -   
  OSE Immunotherapeutics Propose une Evolution de sa Gouvernance et Réaffirme ses Priorités Stratégiques à l’Approche de son Assemblée Générale Annuelle25/08/2025
-   
  Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector25/08/2025
-   
  HUTCHMED Announces Appointment of Acting Chief Executive Officer25/08/2025
-   
  La marque suisse légendaire BILATTE inaugure l’ère 3.0 des soins esthétiques médicaux à domicile24/08/2025
-   
  A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care24/08/2025
-   
  Celularity Receives Nasdaq Notice Regarding Form 10-Q22/08/2025
-   
  Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)22/08/2025
-   
  Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor22/08/2025
-   
  MEDIROM launches cryptocurrency strategy with next-generation proof of human technology, "World"22/08/2025
-   
  Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma22/08/2025
-   
  Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions22/08/2025
-   
  Des pas en alimentation durable… mais trop petits pour bien nourrir tout le Québec22/08/2025
-   
  Human Appeal launches emergency appeal to deliver 12,000 hot meals in Pakistan22/08/2025
-   
  Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares22/08/2025
-   
  Simple Consult Launches $29 Insurance-Free Online Medical Consultations22/08/2025
-   
  Legendary Swiss Brand BILATTE Ushers In Home Medical Beauty Care 3.0 Era22/08/2025
-   
  Trading by management and close relations of management22/08/2025
-   
  Fifty1 Labs, Inc. Subsidiary Fifty1 AI Labs Partners with ViRx@Stanford Under 'BE READI!' Initiative to Advance AI-Powered Antiviral Drug Repurposing22/08/2025
-   
  NMDP Named ‘Best Place to Work’ Fifth Year in a Row22/08/2025
Pages